|
|
||||||||
1From the Evelyn F. and William L. McKnight Vision Research Center, Bascom Palmer Eye Institute, University of Miami School of Medicine, Miami Florida; the 2Schepens Eye Research Institute and Departments of Ophthalmology and Cell Biology, Harvard Medical School, Boston Massachusetts; and the 3Department of Biology, College of Natural Sciences, Kyungpook National University, Taegu, Korea.
| Abstract |
|---|
|
|
|---|
METHODS. A penetrating keratectomy rabbit model was adapted for mice to study the fibrotic repair response. A mouse epithelial abrasion model was applied to study the stromal cell replacement response. A primary rabbit corneal cell culture model and an organotypic culture model were also used.
RESULTS. When the epithelium was prevented from resurfacing the cornea after penetrating keratectomy, expression of fibrotic markers was considerably reduced. TGF-ß2 was determined to be a major substance produced by corneal epithelial cells capable of inducing the fibrotic phenotype. In the intact mouse cornea, TGF-ß2 was confined to the uninjured epithelium, but was released into the stroma during fibrotic repair. By contrast, TGF-ß1 was never found in the epithelium. When epithelial cells were cultured on a basement-membranelike gel or allowed to deposit their own basement membrane in organotypic culture, TGF-ß2 production was reduced. Return of a basement membrane after wounding in vivo correlated with loss of the fibrotic phenotype. In the epithelial debridement injury model in which the basement membrane was left intact, TGF-ß2 remained confined to the corneal epithelium, consistent with the absence of a fibrotic phenotype.
CONCLUSIONS. These data suggest that integrity of the basement membrane is a deciding factor in determining the regenerative character of corneal repair.
The corneas simple cellular organization provides a particularly useful model for studying wound-healing events. Like skin, the cornea comprises a collagenous stroma surfaced by a squamous epithelium. Penetrating incision or ablation injury to the corneal stroma stimulates a typical fibrotic repair response involving hypercellularity, expression of smooth muscle actin, and deposition of a disorganized extracellular matrix (ECM).3 4 5 This repair tissue, which is comparable to a spot weld, is remodeled over time into a mature scar. Its deposition is undesirable in the cornea, because it causes opacity and because the contraction associated with remodeling alters corneal curvature and the capacity to focus light on the retina. For this reason, surgical procedures to correct refractive error in the cornea must be designed to minimize the fibrotic repair response.
The fibrotic response in vascularized tissues is controlled by bioactive substances released from platelets at the wound site, in particular, the cytokines platelet-derived growth factor (PDGF) and transforming growth factor (TGF)-ß. Topical application of a panspecific neutralizing antibody to TGF-ß after corneal injury reduces stromal fibrosis, indicating that similar agents are active in corneal repair.6 However, the cornea contains no blood vessels and heals avascularly. Results of historic investigations have suggested that the epithelium may produce substances that substitute for those produced by platelets.7 Recent clinical observation supports this hypothesis and suggests further that the key to limiting fibrosis is to reduce the potential for epithelial interaction with stromal cells. Thus, debridement of the corneal epithelium from its basement membrane causes underlying stromal cells to undergo apoptosis; however, these cells are simply replaced by mitosis, with no obvious hypercellularity or deposition of matrix.8 It is only if epithelial debridement is followed by penetration of the basement membrane and stromal ablation, as in photorefractive keratectomy (PRK), that the fibrotic response is stimulated. In a newer corrective procedure, laser in situ keratomileusis (LASIK), which involves laser ablation beneath a stromal flap created by microkeratome, basement membrane is penetrated only around the edges of the flap. In this case, keratocytes that die around the ablation site are replaced without expression of fibrotic markers.9 The outcome is a clearer cornea without the haze or remodeling associated with fibrotic repair.
In the current study we investigated the nature of the molecular mediator of epithelialstromal interaction controlling corneal fibrosis and the role of the epithelial basement membrane in limiting this response.
| Materials and Methods |
|---|
|
|
|---|
A rabbit penetrating keratectomy model was adapted for mice to study fibrotic repair.10 11 Briefly, a 1-mm full-thickness button of central corneal tissue including all three corneal tissue layersepithelium, stroma, and endotheliumwas ablated. The area was scored by insertion and removal of a 26-gauge needle into the central cornea. The full-thickness tissue button that was demarcated by the needle insertion was then removed with microdissecting scissors. After approximately 15 minutes, a fibrin clot formed in the space, enabling the anterior chamber to reform.
A previously characterized mouse epithelial debridement model was used to investigate the stromal cell replacement response. The surgical procedure, as adapted for mice, was previously described.12 Briefly, the central epithelium was debrided using an Alger brush within a 1.5-mm region, leaving the basement membrane intact. Within 1 day, stromal cells beneath the debrided area are lost by apoptosis.8
Immunohistochemical Analysis
After surgery, eyes were embedded in optimal cutting temperature (OCT) embedding medium (Tissue Tek, Elkhart, IN) for cryosectioning. Cryosections (10 µm) were prepared from frozen eyes. For visualizing smooth muscle actin (
-sm actin) and filamentous actin, sections were fixed in 4% paraformaldehyde (PFA) for 10 minutes. Direct immunofluorescence for
-sm actin was performed with a primary FITC-conjugated monoclonal anti-
-sm actin antibody (Sigma-Aldrich, St. Louis, MO). Filamentous actin was visualized with rhodamine-conjugated phalloidin (Molecular Probes, Eugene, OR). For TGF-ß1 and -ß2 indirect immunohistochemistry, tissue was fixed in ice-cold acetone for 10 minutes and incubated with rabbit polyclonal antibodies (Santa Cruz Biotechnology, Santa Cruz, CA) overnight. Secondary detection used an anti-rabbit Vectastain ABC kit (Vector Laboratories, Burlingame, CA). Basement membranes were detected by indirect immunofluorescence. For detection of entactin, sections were fixed in ice-cold acetone and incubated with a monoclonal anti-entactin antibody (Chemicon, Temecula, CA) followed by secondary anti-rat rhodamine (Chemicon). For detection of laminin, sections were fixed in 3% PFA and incubated with a sheep polyclonal antiserum raised against mouse laminin (a gift from Ilene Gipson, Schepens Eye Research Institute, Boston, MA), followed by a FITC-conjugated donkey anti-sheep antibody (Jackson ImmunoResearch, Inc., West Grove, PA). Before mounting immunofluorescent sections, nuclei were localized by staining with 4', 6-diamidino-2-phenylindole (DAPI; 10 ng/mL). Images of sections were captured on a microscope (Nikon, Tokyo, Japan). Images for each experiment were obtained using the same camera settings. Quantification of immunofluorescence was performed on computer (Image Pro-Plus; MediaCybernetics, Silver Spring, MD).
Cell Culture and Organotypic Culture
Eyes of New Zealand White rabbits were obtained from Pel Freez Co. (Rogers, AR), and primary stromal and epithelial cell cultures were prepared as previously described.13 Corneal organotypic cocultures were also made as previously described.14 Briefly, a mouse corneal endothelial cell line15 was seeded atop a polycarbonate membrane. A type I collagen solution was seeded with rabbit corneal stromal cells and placed over the endothelial cells. Rabbit corneal epithelial cells were then plated atop the construct, thus mimicking corneal structure. Some cultures were treated with TGF-ß2 (Sigma-Aldrich).
Epithelial cell cultures were plated on plastic tissue culture dishes, synthetic matrix-coated plates (Matrigel), or plates coated with collagen (BD Biosciences, Bedford, MA). For epithelial cellconditioned media, epithelial cells were plated in 10-cm tissue culture dishes in serum-free medium and allowed to condition the medium for 72 hours. Medium was then collected and cell debris was spun down. Media were stored at -80°C for further use. For neutralizing antibody experiments anti-TGF-ß1 (AF-101-NA; R&D Systems, Minneapolis, MN) and anti-TGF-ß2 (AB-112-NA; R&D Systems) was used to treat conditioned epithelial medium before use. Anti-TGF-ß1 was used at 0.2 µg/mL and anti-TGF-ß2 was used at 2 µg/mL. Antibody concentrations were chosen to give 50% maximum inhibition of cell replication when tested on an indicator cell line.
Western Blot Analysis
Cells were plated in six-well dishes at 1 x 106 cells per well and allowed to condition the media for 48 hours. Media were then collected, and secreted proteins were precipitated with 10% ice-cold trichloroacetic acid (TCA). Proteins were redissolved in radioimmunoprecipitation assay (RIPA) buffer (1% NP-40, 0.5% deoxycholate, 0.1% SDS). Total secreted protein from equivalent cell numbers was then run on a 12% polyacrylamide gel for Western analysis. For cell lysates, stromal cells or epithelial cells were digested in RIPA with a protease inhibitor cocktail (Complete mini; Roche Diagnostics, Indianapolis, IN). Epithelial cell lysates were then TCA precipitated before Western blot analysis. For Western analysis, anti-TGF-ß1 (AF-101-NA; R&D Systems) was used at 1:1000, anti-TGF-ß2 (AB-112-NA; R&D Systems) at 1:500, and anti
-sm actin (Sigma-Aldrich) at 1:3000.
| Results |
|---|
|
|
|---|
-sm actin (Fig. 1 , green), a marker of fibrotic repair. Control corneas showed no staining for either marker, nor were the uninjured areas of tissue stained in debrided corneas (not shown). Corneal stromas were still negative for the repair markers at day 5 after injury. However, by day 7, there was robust staining for both markers in the hypercellular repair tissue and stress fibers strongly colocalized with
-sm actin. By day 14 after injury, staining for both markers had regressed and appeared only beneath the regenerated epithelium, even though the tissue remained hypercellular. These data show that the fibrotic phenotype is temporally and spatially regulated during corneal wound repair.
|
-sm actin was significantly reduced by this procedure. Quantification of mean fluorescence intensity revealed a 60% reduction in
-sm actin staining (P < 0.01, Students paired t-test). Stress fiber organization was also reduced in debrided corneas but to a lesser extent, a 40% reduction was observed (P < 0.02, Students paired t-test). DAPI staining revealed an abundance of cells in both debrided and control corneas. Immunostaining for the Mac1 marker indicated that debridement causes an increase in inflammatory cell infiltration in the anterior aspect of the stroma. Nevertheless, there were many DAPI staining nuclei outside the region of Mac1 staining, indicating that loss of fibrotic markers is not due to a loss of repair cells. These data suggest that the repair cell phenotype is controlled by exposure to the regenerating epithelium.
In contrast to skin, the corneal stroma contains a homogenous population of stromal cells (keratocytes) without specialized functions, providing a relatively pure population of cells for isolation into culture. Using this cell culture model, epithelial factors have been identified that control aspects of stromal cell activation in vitro.17 In an attempt to identify the epithelial factors controlling expression of fibrotic markers, we used an in vitro assay. Rabbit corneal stromal cells freshly isolated from the corneal stroma and cultured in the absence of serum have a dendritic appearance, true to their in vivo phenotype in the uninjured cornea16 (Fig. 2A) . Treatment of cells with TGF-ß2 stimulated cellular spreading to a fibroblast spindle shape (representative results shown in Fig. 2A ) and development of stress fibers as examined by rhodamine phalloidin staining (data not shown). Treatment of stromal cells with conditioned media from cultured rabbit corneal epithelial cells induced a similar change in phenotype as treatment with TGF-ß2. Addition of a neutralizing antibody to TGF-ß2 but not TGF-ß1 inhibited the phenotypic change. Treatment of stromal cells with conditioned media induced a level of
-sm actin expression similar to treatment with TGF-ß (Fig. 2B) . Neutralizing antisera to TGF-ß2 but not the TGF-ß1 isoform, inhibited the potential of conditioned epithelial media to induce
-sm actin, suggesting TGF-ß2 was at least one of the active agents.
|
Spatial and Temporal Patterns of TGF-ß Isoforms during Corneal Wound Healing
To determine the sources of TGF-ßs during fibrotic corneal wound repair in vivo, we used immunohistochemistry. Immunoreactive TGF-ß2 was present in the unwounded corneal epithelium and was expressed in this tissue throughout healing (Fig. 3A) . By day 3 after surgery, TGF-ß2 localized to the fibrin clot within the wound region. Day 7 showed strong TGF-ß2 immunolocalization to the region directly beneath the epithelium within the wound area. Positive immunostaining remained within the wound region through day 14 and subsequently decreased until no TGF-ß2 was detected by day 24.
|
Effect of Basement Membrane Regulation of Epithelial TGF-ß2 on Fibrotic Activation
We questioned whether a proper epithelial substratum was capable of regulating release of TGF-ß2 into the stroma. Corneal epithelial cells were plated either on plastic culture dishes or basement membrane matrix (Matrigel; BD Bioscience)coated tissue culture dishes and conditioned media were examined for the presence of TGF-ß isoforms (Fig. 4A) . TGF-ß1 release from corneal epithelial cells was variable and not regulated by plating on the matrix. In contrast, TGF-ß2 was consistently downregulated in corneal epithelial cellconditioned media when plated on synthetic matrix. Plating epithelial cells on collagen I, collagen IV, or laminin did not show a similar effect (data not shown). We then compared internal and external cellular pools of TGF-ß2 by Western analysis to determine whether the decrease in detectable TGF-ß2 in media of epithelial cells plated on synthetic matrix reflected a decrease in protein expression or a decrease in protein secretion. Epithelial cells plated on matrix decreased TGF-ß2 levels intracellularly and extracellularly to a similar level (Fig. 4B) . This suggested that the decrease in secreted protein was due to a decrease in cellular production of the TGF-ß2 isoform.
|
-sm actin (Fig. 4C) . In the presence of endothelial cells, and therefore a complete basement membrane, stromal cells showed no staining for
-sm actin. These two types of organotypic cultures were immunostained for the TGF-ß2 isoform (Fig. 4C) . In the absence of basement membrane, the stroma stained strongly for TGF-ß2. In the presence of basement membrane, TGF-ß2 was absent in the stroma, and only the epithelium stained positive, mimicking normal unwounded cornea. Therefore, endogenous basement membrane formation in organotypic coculture prevents fibrotic marker expression through inhibition of TGF-ß2 release into the stroma.
We then examined fibrotic corneal repair in vivo to determine whether return of the basement membrane after wounding correlates with a reduction in
-sm actinpositive stromal cells. Basement membrane was examined by immunostaining for entactin, a known corneal epithelial basement membrane component. Entactin localized to the unwounded cornea as a band directly beneath the epithelium, with no staining for
-sm actin within the stromal region (Fig. 5) . Seven days after wounding, entactin was absent from the area beneath the epithelium; however, a diffuse haze was present in the corneal stroma. The stromal staining of entactin was not surprising, as entactin is reported to be produced predominantly by mesenchymal cells in other organs during development19 and is expressed in granulation tissue during skin repair until healing is complete.20 During the complete absence of entactin localization to the basement membrane region at day 7,
-sm actin staining was strongest within the corneal stroma. By 10 days, entactin staining was strong throughout the stromal region, with a slightly more intense staining beneath the epithelium. At the 10-day time point,
-sm actin expression was still strong within the stroma. Finally, by 14 days, entactin relocalized as a band of intense staining directly beneath the epithelium with a marked reduction of
-sm actin in the stroma. These data show that,
-sm actin expression in the corneal stroma during fibrotic wound repair was inversely correlated with the return of basement membrane, as examined by immunolocalization of entactin. Furthermore, basement membrane return after wounding at approximately day 14 in the mouse model correlated with the beginning decline in TGF-ß2 levels within the wound as examined by immunohistochemistry (Fig. 3A) .
|
-sm actin at any time during the period when cells were undergoing replacement. Immunohistochemistry for TGF-ß2 revealed that unlike in fibrotic repair, this isoform remains localized to the epithelium and was never detected in the stroma during this more regenerative form of repair. The lack of TGF-ß2 in the stroma probably explains the failure of stromal cells to express
-sm actin after epithelial debridement.
|
| Discussion |
|---|
|
|
|---|
Basement Membrane Regulation of Corneal Fibrosis
Corneal epithelial cell release of TGF-ß2 was downregulated by plating cells on reconstituted basement membrane, as well as when epithelial cells were allowed to produce endogenous basement membrane. Furthermore, reappearance of an intact basement membrane during fibrotic wound repair in vivo correlated with loss of
-sm actin expression and TGF-ß2 localization within the wound region. Therefore, in our current model, epithelial migration over a nonbasement-membrane matrix signals an increase in production and release of the TGF-ß2 isoform. The return of the basement membrane during healing then signals a decrease and possibly creates a physical barrier to TGF-ß2. The fibrotic phenotype is unstable, because removal of TGF-ß from cultures results in reduced expression of
-sm actin and stress fibers.22 Therefore, during corneal repair the loss of TGF-ß in the stroma due to return of the basement membrane would result in a loss of the fibrotic phenotype.
Not all types of corneal injuries result in a fibrotic stromal cell response. Epithelial damage without basement membrane loss results in activation of adjacent stromal cells, the result is a complete cellular replacement without fibrotic marker expression and no further matrix remodeling.8 During this regenerative response, the basement membrane is left intact, which explains the absence of TGF-ß2 and
-sm actin expression in the stroma. Therefore, basement membrane integrity may be a deciding factor in the extent of fibrosis that develops during corneal wound repair.
The role of TGF-ß1 in corneal repair was not addressed by the experiments in this study, because our findings did not implicate this isoform in controlling the epithelialstromal interaction under study. The localization of TGF-ß1 within the early fibrin clot suggests that it is produced by infiltrating inflammatory cells. It is likely that it is involved in the resolution of the inflammatory response, as has been shown in other wound models. At later times during the repair process, TGF-ß1 was localized to the endothelium, where it may be involved in endothelial repair.23 24 25
Developmental Correlation
Despite seemingly redundant effects, TGF-ß1 and TGF-ß2 have different expression patterns during embryogenesis and wound repair in a number of organs.26 27 28 29 Furthermore, knockout mice have no overlapping phenotypes. Unlike TGF-ß1 deficiency which results in 50% prenatal lethality due to defective hematopoiesis and vasculogenesis, TGF-ß2 deficiency results in multiple developmental defects in numerous organs, including heart, craniofacial, inner ear, and cornea.30 31 32 33 The developmental defects affected by TGF-ß2 deficiency have led to the hypothesis that this isoform is involved in epithelialmesenchymal interactions in cell growth, extracellular matrix production, and tissue remodeling during development.30 This interaction is probably necessary during corneal stroma development where TGF-ß2 knockout mice show a failure to form the corneal stroma due to a significant decrease in stromal cell synthesis of matrix components.31 Furthermore TGF-ß2, unlike TGF-ß1, is expressed constitutively in the epithelium.31 34 Therefore, our data suggest that the epithelialstromal interaction during corneal repair in the adult is a recapitulation of a developmental event with an altered stromal cell response. Understanding why developmental exposure to TGF-ß2 leads to proper corneal stromal development when exposure in the adult leads to fibrosis may shed light on the ability of fetuses to heal scar free. Whether mesenchymal stromal cells have an innate response to TGF-ß different from the adult, or some environmental cofactor present or absent during development, such as an ECM component, decides the fate of the TGF-ß response needs further elucidation.
Basement membrane regulation of stromal phenotypes during wound repair may similarly occur during corneal stromal developmental. TGF-ß2 production, presumably from the corneal epithelium, is necessary for mesenchymal cells to form the corneal stroma properly, beginning at approximately embryonic day (E)12.5 of mouse development.31 Basement membrane during this time is not complete, as examined by immunolocalization of matrix components. Laminin 5, an ECM molecule in hemidesmosomes, does not localize to the corneal basement membrane until E16.35 Therefore, it is possible that an incomplete epithelial basement membrane during embryogenesis allows for the release of TGF-ß2 into the stroma, signaling its development while formation of a proper basement membrane at a later time point signals cessation.
Clinical Significance
Historic studies have demonstrated that changes in corneal stromal cells associated with fibrotic activation fail to occur in the absence of an overlying epithelium.7 The clinical impression has supported the concept that the corneal epithelium controls fibrotic activation.5 9 Our data suggest that the mechanism for this difference in refractive surgeries is the maintenance of the basement membrane, preventing release of the TGF-ß2 isoform. This would explain the lower degree of surgical complication due to scarring in LASIK compared with other procedures such as PRK.36 An even newer procedure, laser subepithelial keratomileusis (LASEK), may reduce haze by the same mechanism. This procedure uses alcohol treatment of the ocular surface to displace the epithelium as an intact flap, which is then folded back into place after laser ablation is performed. A recent study indicates that the basement membrane splits from the underlying stroma with alcohol treatment and stays with the epithelium.37 Overall, our findings have implications for further refinement of corneal refractive surgical procedures.
The importance of a proper epithelial substratum for maintaining stromal homeostasis is supported by the results of studies suggesting that persistent corneal epithelial defects can be healed by application of amniotic membrane, which contains a prominent basement membrane. Amniotic membrane aids re-epithelialization and reduces inflammation and scarring.38 Plating epithelial cells on amniotic membrane matrix is reported to reduce expression of IL-1
, a cytokine hypothesized to be involved in epithelialstromal interactions in the cornea.39 It would be interesting to determine whether amniotic membrane has a similar effect on epithelial TGF-ß2 production, which could play a role in the membranes antiscarring properties.
Investigations into epithelialstromal interactions during wound repair are not specific to the cornea and have been shown to correlate with pathologic healing in other organs. Bronchial changes during pathogenesis of asthma, cystic fibrosis, and chronic obstructive pulmonary disease (COPD) have been postulated to involve a similar tissue-inductive event.40 41 Bronchial epithelial cells, similar to corneal epithelium, express factors capable of regulating aspects of bronchial stromal cell wound activation.42 43 44 Bronchial epithelial cell cultures also spontaneously produce predominantly the TGF-ß2 isoform in culture.44 Furthermore, bronchial stromal cell induction of
-sm actin expression45 and an abnormal basement membrane46 47 correlate with disease. Epithelial abnormalities have similarly been shown in hypertrophic scarring in skin where the epithelium is reported "activated" and expressing an increase in cell cycle markers and keratins.48 49 Furthermore, in a porcine model of skin repair, TGF-ß2 is the first isoform expressed in the keratinocytes, whereas in mice, this isoform was reported to be abundantly expressed beneath the hyperproliferative epithelium.28 29 Therefore a similar epithelial/stromal interaction involving the TGF-ß2 isoform may occur in skin as well.
| Conclusion |
|---|
|
|
|---|
| Acknowledgements |
|---|
| Footnotes |
|---|
Submitted for publication November 20, 2002; revised April 29, 2003; accepted April 30, 2003.
Disclosure: B.M. Stramer, None; J.D. Zieske, None; J.-C. Jung, None; J.S. Austin, None; M.E. Fini, None
The publication costs of this article were defrayed in part by page charge payment. This article must therefore be marked "advertisement" in accordance with 18 U.S.C.
1734 solely to indicate this fact.
Corresponding author: M. Elizabeth Fini, McKnight Vision Research Center, Bascom Palmer Eye Institute, University of Miami School of Medicine, PO Box 016880, Miami, FL 33101; efini{at}med.miami.edu.
| References |
|---|
|
|
|---|
This article has been cited by other articles:
![]() |
A. Ivarsen, W. Fledelius, and J. O. Hjortdal Three-Year Changes in Epithelial and Stromal Thickness after PRK or LASIK for High Myopia Invest. Ophthalmol. Vis. Sci., May 1, 2009; 50(5): 2061 - 2066. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Xing and J. A. Bonanno Effect of cAMP on TGF{beta}1-Induced Corneal Keratocyte-Myofibroblast Transformation Invest. Ophthalmol. Vis. Sci., February 1, 2009; 50(2): 626 - 633. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. R. Fournie, G. M. Gordon, D. G. Dawson, H. F. Edelhauser, and M. E. Fini Correlations of Long-term Matrix Metalloproteinase Localization in Human Corneas After Successful Laser-Assisted In Situ Keratomileusis With Minor Complications at the Flap Margin Arch Ophthalmol, February 1, 2008; 126(2): 162 - 170. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Ebihara, S. Yamagami, L. Chen, T. Tokura, M. Iwatsu, H. Ushio, and A. Murakami Expression and Function of Toll-like Receptor-3 and -9 in Human Corneal Myofibroblasts Invest. Ophthalmol. Vis. Sci., July 1, 2007; 48(7): 3069 - 3076. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Meltendorf, G. J. Burbach, J. Buhren, R. Bug, C. Ohrloff, and T. Deller Corneal Femtosecond Laser Keratotomy Results in Isolated Stromal Injury and Favorable Wound-Healing Response Invest. Ophthalmol. Vis. Sci., May 1, 2007; 48(5): 2068 - 2075. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. J. LaGier, S. H. Yoo, E. C. Alfonso, S. Meiners, and M. E. Fini Inhibition of Human Corneal Epithelial Production of Fibrotic Mediator TGF-{beta}2 by Basement Membrane-Like Extracellular Matrix Invest. Ophthalmol. Vis. Sci., March 1, 2007; 48(3): 1061 - 1071. [Abstract] [Full Text] [PDF] |
||||
![]() |
Z. Li, A. R. Burns, and C. W. Smith Lymphocyte Function-Associated Antigen-1-Dependent Inhibition of Corneal Wound Healing Am. J. Pathol., November 1, 2006; 169(5): 1590 - 1600. [Abstract] [Full Text] [PDF] |
||||
![]() |
Z. Li, A. R. Burns, and C. W. Smith Two Waves of Neutrophil Emigration in Response to Corneal Epithelial Abrasion: Distinct Adhesion Molecule Requirements Invest. Ophthalmol. Vis. Sci., May 1, 2006; 47(5): 1947 - 1955. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. J. Dwivedi, G. F. Pontoriero, R. Ashery-Padan, S. Sullivan, T. Williams, and J. A. West-Mays Targeted Deletion of AP-2{alpha} Leads to Disruption in Corneal Epithelial Cell Integrity and Defects in the Corneal Stroma Invest. Ophthalmol. Vis. Sci., October 1, 2005; 46(10): 3623 - 3630. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. E. K. Hutcheon, X. Q. Guo, M. A. Stepp, K. J. Simon, P. H. Weinreb, S. M. Violette, and J. D. Zieske Effect of Wound Type on Smad 2 and 4 Translocation Invest. Ophthalmol. Vis. Sci., July 1, 2005; 46(7): 2362 - 2368. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Yoshida, S. Shimmura, J. Shimazaki, N. Shinozaki, and K. Tsubota Serum-Free Spheroid Culture of Mouse Corneal Keratocytes Invest. Ophthalmol. Vis. Sci., May 1, 2005; 46(5): 1653 - 1658. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. E. Gabison, S. Mourah, E. Steinfels, L. Yan, T. Hoang-Xuan, M. A. Watsky, B. De Wever, F. Calvo, A. Mauviel, and S. Menashi Differential Expression of Extracellular Matrix Metalloproteinase Inducer (CD147) in Normal and Ulcerated Corneas: Role in Epithelio-Stromal Interactions and Matrix Metalloproteinase Induction Am. J. Pathol., January 1, 2005; 166(1): 209 - 219. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. M. Stramer and M. E. Fini Uncoupling Keratocyte Loss of Corneal Crystallin from Markers of Fibrotic Repair Invest. Ophthalmol. Vis. Sci., November 1, 2004; 45(11): 4010 - 4015. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Ivarsen, T. Laurberg, and T. Moller-Pedersen Role of Keratocyte Loss on Corneal Wound Repair after LASIK Invest. Ophthalmol. Vis. Sci., October 1, 2004; 45(10): 3499 - 3506. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. A. K. Harvey, S. C. Anderson, and N. SundarRaj Downstream Effects of ROCK Signaling in Cultured Human Corneal Stromal Cells: Microarray Analysis of Gene Expression Invest. Ophthalmol. Vis. Sci., July 1, 2004; 45(7): 2168 - 2176. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. M. Stramer, M. G. K. Kwok, P. J. Farthing-Nayak, J.-C. Jung, M. E. Fini, and R. C. Nayak Monoclonal Antibody (3G5)-Defined Ganglioside: Cell Surface Marker of Corneal Keratocytes Invest. Ophthalmol. Vis. Sci., March 1, 2004; 45(3): 807 - 812. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |